News
This rheumatic disease affects 24% of Spaniards aged 45 and olderIt is estimated that by 2020 osteoarthritis will become the fourth most common cause of disability because of the population longer life expectancy and progressive ageing.Apart from ageing, the other factors leading to the development of osteoarthritis are obesity, genetic predisposition and joint overuse.The role of family physi
Elite competition, injuries and joint overuse, among the major risk factors that may end up causing osteoarthritis.Dr. Villalón, head of the Club Atlético de Madrid medical department, points out that the chances of a sportsperson of developing osteoarthritis increase after suffering a knee trauma.
MOVES is a new multicenter clinical essay involving 560 patients from Spain, Germany, France and Poland.The aim of the MOVES project (Multicenter Osteoarthritis InterVEntion trial with Sysadoas) is to contribute further evidence of the efficacy and security of the combination of chondroitin sulfate and glucosamine in the treatment of knee osteoarthritis patients with moderate to severe pain.
Condrovet Taste evolves: now it is sold in boxes of 40, 80, 120 or 140 capsules. This new package design replaces the old boxes of 60, 100, 140 or 240 capsules.
BIOIBERICA presents new containers for its Condrovet Taste and Cosequin Taste HA range of products